bullish
InnoCare (诺诚健华) Pre-IPO: PHIP and Valuation Update
501 Views04 Mar 2020 13:24
InnoCare Pharma Limited is a clinical-stage biopharmaceutical company with a focus on small molecule inhibitors for BTK, and FGFRs. The company...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- ECM Weekly (15 Mar 2020) - SBI Cards, SCG Package, Innocare, Akesobio, Zhenro Services15 Mar 2020
- InnoCare (诺诚健华) IPO: Bifurcated Book, Update of Our View13 Mar 2020
- InnoCare (诺诚健华) IPO: Momentum Matters but Mind the Limited Upside11 Mar 2020
- InnoCare (诺诚健华) Pre-IPO: Thoughts on Valuation28 Jan 2020
- InnoCare (诺诚健华) Pre-IPO: A Decent Team but Short of Clinical Stage Candidates21 Oct 2019
x